IO BIOTECH ApS: Financial statements 2023
CVR: 36474483
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
IO BIOTECH ApS (CVR 36474483) has filed annual accounts for 2023. In 2023, the company reported a net result of EUR -76,648,917 compared with DKK -463,037,029 the year before. Equity in the 2023 report amounted to EUR 18,203,452. The solvency ratio was 30.8%. The company had 21 employees in the financial year.
- Profit/Loss
- EUR -76,648,917
- Equity
- EUR 18,203,452
- Total Assets
- EUR 59,038,915
- Employees
- 21
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | - | -76.6 mio. EUR | 18.2 mio. EUR | 21 |
| 2022 | - | - | -463 mio. | 259.7 mio. | 19 |
| 2021 | - | - | -240.4 mio. | 722.8 mio. | 15 |
| 2020 | - | - | -65.2 mio. | 17.5 mio. | - |
| 2019 | - | - | -68.7 mio. | -13.9 mio. | 12 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
IO BIOTECH ApS has published its annual report for 2022. The net result was DKK -463,037,029.
About IO BIOTECH ApS
IO BIOTECH ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2014. The company is under bankruptcy. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company is owned by IO Biotech Inc.. The company has 9 employees (2026). In 2024, the company reported a net result of EUR -84,833,635 compared with EUR -76,648,917 the year before. Equity in the 2024 report amounted to EUR -6,630,183.